Howton David T 4

What Happened

• David T. Howton, Chief Operating Officer of Solid Biosciences (SLDB), disposed of 18,894 shares on 2026-02-04 via an open‑market sale. The weighted average sale price was $6.44 per share (sales ranged from $6.28 to $6.60), for total gross proceeds of about $121,713. This was a sale, not a purchase.

Key Details

• Transaction date: 2026-02-04; Form 4 filed: 2026-02-06 (timely filing).
• Shares sold: 18,894; weighted average price: $6.44; price range: $6.28–$6.60.
• Total proceeds: ~$121,713.
• Shares owned after transaction: not disclosed in the provided excerpt of the filing.
• Footnote F1: Sale was executed under a durable automatic sell‑to‑cover instruction to satisfy withholding taxes following RSU vesting and was not a discretionary trade by Mr. Howton.
• Footnote F2: Reported price is a weighted average; the filer can provide a breakdown of shares sold at each price upon request.

Context

• This was a routine sell‑to‑cover to meet tax withholding obligations after restricted stock units vested; such transactions are common and generally not interpreted as an independent signal of the insider’s view on the company’s stock.
• No option exercises, gifts, or 10% owner transactions are involved here.